Renata’s profits rise 22% to Tk 506cr
Profits of Renata Ltd, a listed drug maker, soared over 22 per cent year-on-year to Tk 506 crore in 2020-21 amid the Covid-19 pandemic.
On the basis of the profit, the pharmaceutical company’s board of directors recommended 145 per cent cash and 10 per cent stock dividends for shareholders.
Today, the company made the announcement in a board meeting.
The company’s earnings per share stood at Tk 51.94 in the recently ended financial year which was Tk 46.62 a year earlier.
Renata got listed with the Dhaka Stock Exchange (DSE) in 1979 and it now has a paid-up capital of Tk 97.4 crore, according to the DSE data.
Sponsors and directors of the company hold 51.18 per cent stakes of the company.